Research.Patient.info

Bioequivalence study under fasting conditions research hub

2 indexed studies · 0 currently recruiting

ongoing, recruitingHuman Pharmacology (Phase I)- Bioequivalence Study
Open-label, randomized, two-period, two-treatment, two-sequence, crossover, balanced, study to assess the bioequivalence between the test product Betahistine dihydrochloride 24 mg tablets from Esperante Development BV and reference product Betaserc® 24 mg tablets.
This study compares a new betahistine tablet to an existing one. It's to see if they both work the same way in your body when taken on an empty stomach. This helps ensure new medicines are just as effective as trusted ones.
Czechia
ongoing, recruitingHuman Pharmacology (Phase I)- Bioequivalence Study
The pivotal bioequivalence study comparing the test product to the reference product, which belongs to the group of medicines used in treatment of schizophrenia in adults patients.
This study is testing if a new version of a schizophrenia medicine works the same way as an existing one. It's for adults, both men and women, who are healthy. It's a very early stage study to check how the medicine acts in the body.
Czechia